Genmab USA News and Activities

Genmab USA is owned by Genmab.

Genmab is one of the...

• Forbes Global 2000 (#1542);
• Stoxx 600;
• TOB Iconic 10,000.

Genmab is a company listed under the stock ticker GMAB (DK).

Genmab has a direct presence in 4 countries.

Genmab has 4 subsidiaries including Genmab Europe, Genmab Japan and Genmab USA.

Acquisition, funding and merger involving Genmab.

• Genmab has acquired Merus Bio (posted on December 30 2025).
• Genmab has announced the acquisition of Merus Bio  (posted on October 27 2025).
• Genmab has acquired Merus (posted on September 30 2025).

View the org chart displaying its 25 main executives

Most searched biographies at Genmab USA

• Brad Bailey, Senior Vice President and General Manager
• John Keating, Senior Vice President, Global Commercialization
• Angelique Gallucci, Senior Director and Head of Development Busine...

Popular executive movements at Genmab

• Robert Doornbos has joined the company as Vice President, Head of Chemistry, Manufacturing and Controls Product Development  (posted on April 3 2026).
• Margarida Duarte has joined the company as General Manager, Europe and Emerging Markets  (posted on April 3 2026).

Create your alert
to follow the executive moves at Genmab USA.

Genmab has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Genmab USA

• Major Shareholder Announcement - Genmab A/S
• Transactions in connection with share buy-back program - Genmab A/S
• Transactions in connection with share buy-back program - Genmab A/S
• Major Shareholder Announcement - Genmab A/S
• Genmab Announces Net Sales of DARZALEX® (daratumumab) for the Second Quarter of 2022 - Genmab A/S
• Genmab Announces That AbbVie Will Submit Marketing Authorization Application to European Medicines Agency for Epcoritamab (DuoBody®-CD3xCD20) for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) - Genmab A/S
• Transactions in connection with share buy-back program - Genmab A/S
• Major Shareholder Announcement - Genmab A/S
• Transactions in connection with share buy-back program - Genmab A/S
• Genmab A/S has published its Articles of Association - Genmab A/S
• View more press releases Close

Social media about Genmab USA

• Genmab USA on Wikipedia, Google News & Yahoo Finance
• Genmab USA on LinkedIn, X (Twitter) & YouTube